IM Cannabis (IMCC) Stock Jumps 34% After Unveiling European Drone Deal

TLDR

• IM Cannabis stock surged about 34% after announcing a proposed defense-tech deal.
• IMCC signed a non-binding LOI to acquire 51% of Space Defense Innovations.
• SDI operates in Europe’s tactical unmanned aircraft systems market.
• The deal includes stock, warrants, seller financing and up to €2.3 million of credit.
• The transaction is not final and remains subject to due diligence and approvals.

IM Cannabis (IMCC) stock surged about 34% Wednesday after the company announced plans to acquire control of a European tactical drone business. IMCC had closed Tuesday at $4.14 before the latest announcement.

IM Cannabis Corp., IMCC

The stock’s move appears primarily tied to IM Cannabis’s proposed acquisition of 51% of Space Defense Innovations, or SDI. The deal would mark a sharp expansion beyond the company’s medical cannabis operations into defense and aerospace technology.

Importantly, this is not a completed acquisition. IM Cannabis has signed a non-binding letter of intent, with the transaction still dependent on due diligence, definitive agreements, regulatory approvals and other closing conditions.

IM Cannabis Targets European Drone Market

SDI is a Polish company operating in the unmanned aerial systems market through its wholly owned BlueAero Group subsidiary. BlueAero distributes BlueBird Aero Systems’ tactical UAS and hybrid fixed-wing vertical takeoff and landing products in Europe, with exclusivity in Poland.

SDI is also expected to become a manufacturer of those systems if it receives the required regulatory licenses. That manufacturing role is therefore prospective and should not be treated as an existing licensed operation.

Under the proposed structure, IM Cannabis would acquire 51% of SDI using common stock and potentially pre-funded warrants. The transaction would also include a 24-month seller loan carrying 9% annual interest.

Warrants covering 100% of the seller-loan principal would be issued with an exercise price set at a 25% premium to IMCC’s closing price when definitive agreements are signed. The structure creates potential dilution for current IMCC investors if those securities are ultimately issued and exercised.

IM Cannabis would also provide SDI with an on-demand credit line of up to €2.3 million at closing. That facility would mature after 36 months and could be converted into SDI equity at IM Cannabis’s discretion.

The company would gain the right to appoint a majority of SDI’s board. It would also receive a five-year option to acquire the remaining 49% at the same valuation used for the initial transaction.

Big Stock Move Comes With Deal Risk

The proposed transaction represents a major strategic shift for a company with a market value of only a few million dollars. IMCC’s small size and limited stock float can also contribute to unusually sharp price moves when new corporate developments are announced.

IM Cannabis has already been exploring opportunities outside medical cannabis. Earlier this year, it signed another non-binding LOI involving Polish defense technology company Blackaxe Technologies, although that transaction was also presented as an exploratory expansion into technology businesses.

The latest proposal comes as IM Cannabis refocuses its cannabis operation primarily on Israel while pursuing new business opportunities. The SDI deal would give the company exposure to tactical drones and European defense spending if it reaches completion.

Investors should also weigh financing risk. The proposed deal includes stock consideration, warrants, debt and a €2.3 million credit commitment, all of which could place pressure on a company with a very small market capitalization.

There is also execution risk because SDI’s planned manufacturing activity depends on obtaining regulatory licenses. The LOI itself can still be changed or terminated, and there is no assurance that definitive agreements will be reached.

For now, the proposed SDI acquisition is the clear driver behind IMCC’s sharp move. The companies aim to negotiate definitive agreements within 60 days, making the next concrete milestone a signed transaction rather than Wednesday’s non-binding announcement.